Tamboran Resources (NYSE: TBN) supplement: 2.96M shares, 3.40M if full greenshoe
Filing Impact
Filing Sentiment
Form Type
424B5
Rhea-AI Filing Summary
Tamboran Resources Corporation filed a supplement to its prospectus supplement dated April 7, 2026 relating to the registration of 2,956,602 shares of common stock. The supplement notes that the amount would be 3,400,093 shares if the underwriters' over-allotment option is exercised in full.
The filing is limited to submitting the Exhibit 107 filing fee exhibit for the underwriters' over-allotment option and does not amend the prior prospectus supplement or the accompanying prospectus.
Positive
- None.
Negative
- None.
Key Figures
Registered shares: 2,956,602 shares
Maximum if greenshoe exercised: 3,400,093 shares
2 metrics
Registered shares
2,956,602 shares
relating to prospectus supplement dated April 7, 2026
Maximum if greenshoe exercised
3,400,093 shares
if the underwriters' over-allotment option is exercised in full
Key Terms
underwriters' over-allotment option, prospectus supplement, Exhibit 107 filing fee exhibit
3 terms
underwriters' over-allotment option financial
"relating to 2,956,602 shares of common stock, (3,400,093 if the underwriters' over-allotment"
prospectus supplement regulatory
"prospectus supplement, dated April 7, 2026 (File No. 333-294908), filed by Tamboran"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Exhibit 107 filing fee exhibit regulatory
"filed solely for the purposes of filing the Exhibit 107 filing fee exhibit"
FAQ
Does the supplement change the original prospectus supplement terms for Tamboran (TBN)?
No. The supplement expressly states it does not amend, modify or alter the prior prospectus supplement or the accompanying prospectus; it is filed solely to provide the Exhibit 107 filing fee exhibit for the over-allotment option.
What is the purpose of the Exhibit 107 filing referenced in Tamboran's supplement (TBN)?
The filing submits the Exhibit 107 filing fee exhibit related to the underwriters' over-allotment option described in the prospectus supplement. The supplement indicates this is the sole purpose and makes no other changes to the offering documents.